Robert Doebele - Apr 13, 2022 Form 4 Insider Report for Rain Therapeutics Inc. (RAIN)

Role
President, Chief Scientific Officer
Signature
/s/ Nelson Cabatuan, Attorney-in-fact for Robert Doebele
Stock symbol
RAIN
Transactions as of
Apr 13, 2022
Transactions value $
$11,850
Form type
4
Date filed
4/15/2022, 04:30 PM
Previous filing
Apr 4, 2022
Next filing
Jul 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RAIN Common Stock Options Exercise $11.9K +3K +0.64% $3.95 473K Apr 13, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RAIN Stock Option (Right to Buy) Options Exercise $0 -3K -25.23% $0.00 8.89K Apr 13, 2022 Common Stock 3K $3.95 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 13,890 shares of Issuer's common stock, which is vested in full.

Remarks:

President, Chief Scientific Officer